Teva Pharmaceutical Industries - 28 Year Stock Price History | TEVA

Historical daily share price chart and data for Teva Pharmaceutical Industries since 1990 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Teva Pharmaceutical Industries as of November 15, 2018 is 22.62.
Teva Pharmaceutical Industries Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 21.1579 19.1100 25.6500 16.6800 22.6200 19.37%
2017 25.1752 36.2877 36.7524 11.1652 18.9500 -46.01%
2016 48.5120 61.4736 62.0008 33.9156 35.0968 -43.20%
2015 57.4253 51.7518 67.0558 50.5644 61.7937 16.73%
2014 46.9148 36.1043 53.7549 35.7635 52.9393 47.29%
2013 34.4799 32.4379 37.1235 32.4379 35.9429 10.36%
2012 35.9346 36.8548 39.4116 32.2286 32.5688 -5.63%
2011 38.5499 44.2345 47.3106 30.0250 34.5118 -21.23%
2010 46.0024 48.0507 53.7257 39.3724 43.8142 -6.06%
2009 39.9240 35.0590 46.7142 34.0725 46.6394 33.28%
2008 36.8902 38.2007 40.4406 30.9902 34.9932 -7.37%
2007 32.8761 25.2087 38.0625 25.2087 37.7780 50.73%
2006 29.2785 35.2174 35.2174 23.8544 25.0635 -27.08%
2005 26.6383 23.1818 36.3841 21.3405 34.3703 45.04%
2004 23.6841 22.8660 27.1200 18.7397 23.6976 5.76%
2003 20.0211 15.4815 24.2331 13.6685 22.4076 47.25%
2002 12.7675 12.1533 15.5918 10.2099 15.2174 25.60%
2001 11.9083 12.9320 14.3495 9.9910 12.1159 -15.74%
2000 10.4833 6.8561 15.3062 6.2984 14.3787 104.78%
1999 4.7438 4.1278 7.0216 3.8962 7.0216 76.63%
1998 3.9448 4.7305 4.8708 3.1335 3.9754 -13.74%
1997 5.3845 4.8025 6.5470 4.1343 4.6087 -5.58%
1996 4.0556 4.4656 4.8939 2.9571 4.8812 8.70%
1995 3.4050 2.3136 4.5624 2.0783 4.4907 92.58%
1994 2.6080 2.9030 3.2868 2.1614 2.3319 -19.33%
1993 2.3858 2.2125 3.2127 1.7820 2.8905 37.70%
1992 1.3099 1.0536 2.1407 0.9589 2.0991 134.77%
1991 0.7238 0.5536 0.9342 0.5183 0.8941 65.02%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $23.053B $22.385B
TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. The company markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions. Key therapeutic areas are the analgesic, anti-infective, cardiovascular, CNS, dermatological and anti-inflammatory categories.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $53.197B 9.13
Mylan (MYL) United Kingdom $17.650B 7.27
Bausch Health Cos (BHC) Canada $9.251B 6.70
Dr Reddy's Laboratories (RDY) India $5.675B 22.66
Mallinckrodt Public Limited Company (MNK) United Kingdom $2.575B 4.29
Supernus Pharmaceuticals (SUPN) United States $2.250B 21.32
Amphastar Pharmaceuticals (AMPH) United States $0.928B 100.65
Akorn (AKRX) United States $0.846B 0.00
Homology Medicines (FIXX) United States $0.747B 0.00
Assembly Biosciences (ASMB) United States $0.569B 0.00
CymaBay Therapeutics (CBAY) United States $0.542B 0.00
Corium (CORI) United States $0.458B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.429B 0.00
Voyager Therapeutics (VYGR) United States $0.366B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.297B 0.00
Teligent (TLGT) United States $0.153B 0.00
Sol-Gel Technologies (SLGL) Israel $0.129B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.091B 0.00
Aevi Genomic Medicine (GNMX) United States $0.073B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.051B 0.00
Evoke Pharma (EVOK) United States $0.046B 0.00
Acasti Pharma (ACST) Canada $0.037B 0.00
Agile Therapeutics (AGRX) United States $0.030B 0.00
China Pharma Holdings (CPHI) China $0.016B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.008B 0.00